Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 54 entries
View as:

Study of the Bioequivalence and Food Effects of HRX0701 Tablets in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05415644 Org: User:
Start: 07/05/22 End: 08/08/22 Due: 08/08/23

A Study of HRS-5346 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

Phase: N/A Priority: Normal
NCT ID: NCT06816264 Org: User:
Start: 02/18/25 End: 12/31/25 Due: 12/31/26

Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT06039254 Org: User:
Start: 09/30/23 End: 12/08/23 Due: 12/08/24

A HR20031 BE Study on Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05682495 Org: User:
Start: 01/31/23 End: 04/04/23 Due: 04/04/24

A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT06816251 Org: User:
Start: 02/25/25 End: 08/31/25 Due: 08/31/26

A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT05879523 Org: User:
Start: 06/05/23 End: 03/21/24 Due: 03/21/25

Multicenter Phase I Study of HRS-6208 in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06727812 Org: User:
Start: 12/27/24 End: 08/31/27 Due: 08/31/28

Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.

Phase: N/A Priority: Normal
NCT ID: NCT06393348 Org: User:
Start: 06/30/24 End: 11/30/25 Due: 11/30/26

A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT07024173 Org: User:
Start: 07/31/25 End: 12/31/27 Due: 12/31/28

A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT05759897 Org: User:
Start: 02/28/23 End: 01/04/24 Due: 01/04/25

A Study to Assess the Effect of Food on HR20033 and Pharmacokinetic After Multiple Dose in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05120219 Org: User:
Start: 10/13/21 End: 12/20/21 Due: 12/20/22

Phase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05851092 Org: User:
Start: 05/26/23 End: 12/31/25 Due: 12/31/26

Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human

Phase: N/A Priority: Normal
NCT ID: NCT06495931 Org: User:
Start: 07/31/24 End: 07/31/24 Due: 07/31/25

A Phase I Single- and Multiple- Ascending Dose and Food Effect Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7535 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05347758 Org: User:
Start: 05/01/22 End: 03/15/23 Due: 03/15/24

A Clinical Study of Mass Balance of [14C]HRS-7535

Phase: N/A Priority: Normal
NCT ID: NCT06819488 Org: User:
Start: 02/27/25 End: 04/16/25 Due: 04/16/26

Safety and Tolerance of Increased Doses of HRS-5346 Tablets in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06441227 Org: User:
Start: 06/13/24 End: 01/09/25 Due: 01/09/26

A HR20031 FE Study on Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05692934 Org: User:
Start: 01/31/23 End: 03/11/23 Due: 03/11/24

Efficacy and Safety of HRS-7535 Tablets in Obese Subjects .

Phase: N/A Priority: Normal
NCT ID: NCT06250946 Org: User:
Start: 02/23/24 End: 01/22/25 Due: 01/22/26

A Phase II Clinical Trial on the Safety, Tolerability, and Efficacy of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT07032077 Org: User:
Start: 06/30/25 End: 07/31/27 Due: 07/31/28

A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06904105 Org: User:
Start: 04/09/25 End: 05/31/26 Due: 05/31/27

A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06922357 Org: User:
Start: 04/24/25 End: 12/31/27 Due: 12/31/28

Bioavailability and Food Effects of HRS-7535 Tablets With Different Formulating Processes in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06422039 Org: User:
Start: 05/15/24 End: 06/15/24 Due: 06/15/25

A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT07021976 Org: User:
Start: 08/31/25 End: 11/30/26 Due: 11/30/27

A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT07021963 Org: User:
Start: 06/30/25 End: 12/31/27 Due: 12/31/28

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1301 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06857253 Org: User:
Start: 03/18/25 End: 08/31/25 Due: 08/31/26